Daytrading Feb 20 Morning, page-2

CYP

Target: $1.30 - $1.50

A MEMS tech company at a very stage was valued at well above $250m at one point, why the World-First MSC breakthrough should not be valued at $250m? or even half of $250m?

CYP is not really hyped at current price, it will retrace after hit high, but it not like some other trading stocks which fundamentals are very weak.


Cynata achieves world-first MSC breakthrough

By Dylan Bushell-Embling   |   Posted in Stem cells on 19 February, 2015
Cynata Therapeutics (ASX:CYP) has achieved a world-first breakthrough of manufacturing mesenchymal stromal cells (MSCs) to therapeutic standards using induced pluripotent stem cells.
- See more at: http://lifescientist.com.au/content...c-breakthrough-860922300#sthash.L2G8Jf6e.dpuf